B-cell expansion as a precursor to splenic MZ lymphoma (MZ) and noncanonical NF-{kappa}B pathways generating marginal zone E{micro}-BCL10 mice exhibit constitutive activation of both canonical

[1]  D. Roopenian,et al.  NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas. , 2008, Cancer research.

[2]  K. Yeh,et al.  Overexpression of B cell-activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma. , 2008, Blood.

[3]  Uri Hershberg,et al.  Frontline : Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites , 2007 .

[4]  C. Berek,et al.  In Vitro and In Vivo Activation Induces BAFF and APRIL Expression in B Cells1 , 2007, The Journal of Immunology.

[5]  M. Du.  MALT lymphoma : recent advances in aetiology and molecular genetics. , 2007, Journal of clinical and experimental hematopathology : JCEH.

[6]  S. Rauser,et al.  MALT1 directs B cell receptor–induced canonical nuclear factor-κB signaling selectively to the c-Rel subunit , 2007, Nature Immunology.

[7]  F. Mackay,et al.  B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. , 2007, Current opinion in immunology.

[8]  Chen-feng Qi,et al.  Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. , 2007, Cancer research.

[9]  H. Noels,et al.  The pathogenesis of MALT lymphomas: where do we stand? , 2007, Leukemia.

[10]  S. Ghosh,et al.  Antigen-Receptor Signaling to Nuclear Factor κB , 2006 .

[11]  D. Rawlings,et al.  The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes , 2006, Nature Reviews Immunology.

[12]  G. Widhopf,et al.  Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.

[13]  P. Marynen,et al.  Selective Expansion of Marginal Zone B Cells in Eμ-API2-MALT1 Mice Is Linked to Enhanced IκB Kinase γ Polyubiquitination , 2006 .

[14]  T. Phan,et al.  Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation , 2006, The Journal of experimental medicine.

[15]  T. Molina,et al.  Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication , 2005, Gut.

[16]  P. Marynen,et al.  Splenic marginal zone lymphoma-like features in API2-MALT1 transgenic mice that are exposed to antigenic stimulation. , 2006, Haematologica.

[17]  S. Tsuzuki,et al.  MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10. , 2005, Blood.

[18]  A. DeFranco,et al.  Bcl10 can promote survival of antigen-stimulated B lymphocytes. , 2005, Blood.

[19]  K. Yeh,et al.  Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). , 2005, Blood.

[20]  A. Nicholson,et al.  MALT lymphoma with t(14;18)(q32;q21)/IGH‐MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression , 2005, The Journal of pathology.

[21]  T. Habermann,et al.  Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. , 2004, Blood.

[22]  J. Kearney,et al.  B Cell Positive Selection: Road Map to the Primary Repertoire? , 2004, The Journal of Immunology.

[23]  T. Phan,et al.  Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.

[24]  A. Rao,et al.  Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-κB Signaling , 2004, Molecular and Cellular Biology.

[25]  F. Ajchenbaum‐Cymbalista,et al.  Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. , 2004, Blood.

[26]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[27]  V. Roschke,et al.  B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. , 2003, Arthritis and rheumatism.

[28]  V. Dixit,et al.  Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase , 2003, Science.

[29]  Jürgen Ruland,et al.  Differential requirement for Malt1 in T and B cell antigen receptor signaling. , 2003, Immunity.

[30]  S. Morris,et al.  Defective development and function of Bcl10-deficient follicular, marginal zone and B1 B cells , 2003, Nature Immunology.

[31]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[32]  S. Akilesh,et al.  Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis. , 2003, Genome research.

[33]  Chris Bakal,et al.  The MAGUK family protein CARD11 is essential for lymphocyte activation. , 2003, Immunity.

[34]  G. Ott,et al.  T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. , 2003, Blood.

[35]  R. Jonsson,et al.  Attenuated Apoptosis of B Cell Activating Factor–Expressing Cells in Primary Sjögren’s Syndrome , 2003, Laboratory Investigation.

[36]  S. Shinton,et al.  Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development , 2003, The Journal of experimental medicine.

[37]  V. Roschke,et al.  BLyS and APRIL Form Biologically Active Heterotrimers That Are Expressed in Patients with Systemic Immune-Based Rheumatic Diseases1 , 2002, The Journal of Immunology.

[38]  N. Harris,et al.  Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.

[39]  D. Baltimore,et al.  The combined absence of NF-κB1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Pillai,et al.  Antigen-dependent B-cell development. , 2002, Current opinion in immunology.

[41]  M. Reth.  Oligomeric antigen receptors: a new view on signaling for the selection of lymphocytes. , 2001, Trends in immunology.

[42]  J. Kearney,et al.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.

[43]  T. Mak,et al.  Bcl10 Is a Positive Regulator of Antigen Receptor–Induced Activation of NF-κ B and Neural Tube Closure , 2001, Cell.

[44]  Bruce H. Horwitz,et al.  Nuclear Factor κb Is Required for the Development of Marginal Zone B Lymphocytes , 2000, The Journal of experimental medicine.

[45]  A. Hagemeijer,et al.  Genetic abnormalities in marginal zone B‐cell lymphoma , 2000, Hematological oncology.

[46]  J. Silver,et al.  Positive selection of natural autoreactive B cells. , 1999, Science.

[47]  J. Kearney,et al.  IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. , 1999, Journal of immunology.

[48]  K. Lennert,et al.  Splenic marginal zone lymphomas of mice. , 1999, The American journal of pathology.

[49]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.